<!DOCTYPE html>
<html class="theme-sleek astro-STCLZLJ5" lang="en">
  <head>
    <!-- Global Metadata -->
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width,initial-scale=1">
    <meta name="theme-color" media="(prefers-color-scheme: light)" content="#ffffff">
<meta name="theme-color" media="(prefers-color-scheme: dark)" content="#18181b">
<!-- 
  This is an example. 
  Use https://realfavicongenerator.net to generate the icons and manifest. 
-->
<link href="/favicon.ico" rel="shortcut icon">

    <!-- Primary Meta Tags --><title>Peripherally Restricted Cannabinoids for the Treatment of Pain.</title>
<meta name="title" content="Peripherally Restricted Cannabinoids for the Treatment of Pain.">
<meta name="description" content="Medical Cannabis Awareness New Zealand">


<!-- Open Graph / Facebook -->
<meta property="og:title" content="Peripherally Restricted Cannabinoids for the Treatment of Pain.">
<meta property="og:description" content="Medical Cannabis Awareness New Zealand">
<meta property="og:type" content="article">
<meta property="og:url" content="https://mcanz.org.nz/blog/peripherally-restricted-cannabinoids-for-the-treatment-of-pain">

<meta property="article:published_time" content="2016-01-23T00:00:00.000Z">





<!-- Twitter -->
<meta property="twitter:title" content="Peripherally Restricted Cannabinoids for the Treatment of Pain.">
<meta property="twitter:description" content="Medical Cannabis Awareness New Zealand">


<meta property="twitter:card" content="summary_large_image">


<!-- {twitter.url && <meta property="twitter:url" content={twitter.url} />} -->

  <link rel="stylesheet" href="/assets/_slug_.2607fc28.css" />
<link rel="stylesheet" href="/assets/_slug_.f022e152.css" /></head>

  <body class="text-text-body bg-bg-body max-w-3xl mx-auto px-4 sm:px-8 astro-STCLZLJ5">
    <header class="astro-FAM4J5CX">
  <a class="skip-to-main astro-FAM4J5CX" href="#main"> Skip to content</a>
  <nav class="astro-FAM4J5CX">
    <section class="astro-FAM4J5CX">
      <ul class="astro-FAM4J5CX">
        <li class="astro-FAM4J5CX"><!-- DO NOT FORMAT. IT ADDS AN EXTRA SPACE ON RENDERED CONTENT. --><a href="/" class="astro-FAM4J5CX header-link unset animated gradient-colors astro-C675TBRQ">Home</a>
</li>
        <li class="astro-FAM4J5CX"><!-- DO NOT FORMAT. IT ADDS AN EXTRA SPACE ON RENDERED CONTENT. --><a href="/blog" class="astro-FAM4J5CX active header-link unset animated gradient-colors astro-C675TBRQ">Blog</a>
</li>
      </ul>
    </section>
  </nav>
</header>

    <main id="main" class="astro-STCLZLJ5">
      <section class="blog-post astro-STCLZLJ5">
        <h1 class="title astro-STCLZLJ5">Peripherally Restricted Cannabinoids for the Treatment of Pain.</h1>
        <time class="publish-date astro-STCLZLJ5">Jan 23, 2016</time>
        <article><p>Authors: <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Romero-Sandoval%20EA%5BAuthor%5D&#38;cauthor=true&#38;cauthor_uid=26497478">Romero-Sandoval EA</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Asbill%20S%5BAuthor%5D&#38;cauthor=true&#38;cauthor_uid=26497478">Asbill S</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Paige%20CA%5BAuthor%5D&#38;cauthor=true&#38;cauthor_uid=26497478">Paige CA</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Byrd-Glover%20K%5BAuthor%5D&#38;cauthor=true&#38;cauthor_uid=26497478">Byrd-Glover K</a>.</p><h3>Abstract</h3><p>The use of cannabinoids for the treatment of chronic diseases has increased in the United States, with 23 states having legalized the use of marijuana. Although currently available cannabinoid compounds have shown effectiveness in relieving symptoms associated with numerous diseases, the use of cannabis or cannabinoids is still controversial mostly due to their psychotropic effects (e.g., euphoria, laughter) or central nervous system (CNS)-related undesired effects (e.g., tolerance, dependence). A potential strategy to use cannabinoids for medical conditions without inducing psychotropic or CNS-related undesired effects is to avoid their actions in the CNS. This approach could be beneficial for conditions with prominent peripheral pathophysiologic mechanisms (e.g., painful diabetic neuropathy, chemotherapy-induced neuropathy). In this article, we discuss the scientific evidence to target the peripheral cannabinoid system as an alternative to cannabis use for medical purposes, and we review the available literature to determine the pros and cons of potential strategies that can be used to this end.</p><p>© 2015 Pharmacotherapy Publications, Inc.</p><p>Full text available for <a href="http://onlinelibrary.wiley.com/doi/10.1002/phar.1642/full">purchase here.</a></p></article>
      </section>
    </main>
    <footer class="astro-5AYKG27L">
  <div class="astro-5AYKG27L">

  </div>
</footer>


  
</body>


</html>